Intech Investment Management LLC Raises Stake in Corteva, Inc. $CTVA

Intech Investment Management LLC boosted its holdings in shares of Corteva, Inc. (NYSE:CTVA) by 287.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 440,478 shares of the company’s stock after purchasing an additional 326,902 shares during the period. Intech Investment Management LLC owned approximately 0.07% of Corteva worth $29,525,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Activest Wealth Management grew its position in Corteva by 118.3% during the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after purchasing an additional 200 shares during the last quarter. JPL Wealth Management LLC purchased a new position in Corteva during the 3rd quarter worth $25,000. Redmont Wealth Advisors LLC purchased a new position in Corteva during the 3rd quarter worth $29,000. Jackson Grant Investment Advisers Inc. grew its position in Corteva by 90.6% during the 3rd quarter. Jackson Grant Investment Advisers Inc. now owns 448 shares of the company’s stock worth $30,000 after purchasing an additional 213 shares during the last quarter. Finally, KERR FINANCIAL PLANNING Corp purchased a new position in Corteva during the 3rd quarter worth $33,000. 81.54% of the stock is owned by hedge funds and other institutional investors.

Corteva Stock Up 0.8%

CTVA stock opened at $80.53 on Friday. Corteva, Inc. has a one year low of $60.53 and a one year high of $85.63. The stock has a market capitalization of $53.86 billion, a PE ratio of 47.37, a price-to-earnings-growth ratio of 2.44 and a beta of 0.59. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47. The company has a fifty day moving average of $81.35 and a 200-day moving average of $74.50.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping the consensus estimate of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. During the same quarter last year, the business earned $1.13 EPS. The business’s revenue was up 11.0% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, analysts expect that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 15th. Investors of record on Monday, June 1st will be paid a $0.18 dividend. The ex-dividend date is Monday, June 1st. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is 42.35%.

Analyst Upgrades and Downgrades

CTVA has been the topic of several research reports. Royal Bank Of Canada raised their price objective on shares of Corteva from $95.00 to $97.00 and gave the stock an “outperform” rating in a research report on Thursday, May 7th. CICC Research raised their price objective on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. JPMorgan Chase & Co. downgraded shares of Corteva from an “overweight” rating to a “neutral” rating and raised their price objective for the stock from $75.00 to $77.00 in a research report on Thursday, February 5th. Zacks Research cut shares of Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. Finally, BNP Paribas Exane raised their target price on shares of Corteva from $74.00 to $77.00 in a research note on Wednesday, May 6th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat.com, Corteva currently has a consensus rating of “Moderate Buy” and an average price target of $88.67.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.